Source: International Journal of Molecular Sciences. Unidade: FCF
Subjects: ARTERIOSCLEROSE, METABÓLITOS SECUNDÁRIOS
ABNT
CUEVAS, Alejandro et al. Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice. International Journal of Molecular Sciences, v. 21, p. 1-18 art. 6417, 2020Tradução . . Disponível em: https://doi.org/10.3390/ijms21176417. Acesso em: 04 jun. 2024.APA
Cuevas, A., Saavedra, N., Salazar, L. A., Cavalcante, M. F., Silva, J. C., & Abdalla, D. S. P. (2020). Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice. International Journal of Molecular Sciences, 21, 1-18 art. 6417. doi:10.3390/ijms21176417NLM
Cuevas A, Saavedra N, Salazar LA, Cavalcante MF, Silva JC, Abdalla DSP. Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice [Internet]. International Journal of Molecular Sciences. 2020 ; 21 1-18 art. 6417.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/ijms21176417Vancouver
Cuevas A, Saavedra N, Salazar LA, Cavalcante MF, Silva JC, Abdalla DSP. Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice [Internet]. International Journal of Molecular Sciences. 2020 ; 21 1-18 art. 6417.[citado 2024 jun. 04 ] Available from: https://doi.org/10.3390/ijms21176417